AA
SRRA

ALPS Advisors’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

ALPS Advisors’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-962
Closed -$70K – 743
2016
Q3 		$70K Sell
962
-98
-9% -$7.57K ﹤0.01% 673
2016
Q2 		$84K Buy
1,060
+215
+25% +$41K ﹤0.01% 605
2016
Q1 		$228K Sell
845
-145
-15% -$46.3K ﹤0.01% 594
2015
Q4 		$596K Buy
+990
New +$670K 0.01% 277

Other funds holding SRRA

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
GT
Greenleaf Trust Kalamazoo, Michigan $10.2B AUM 2.09% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ALPS Advisors's SRRA Position: Q4 2016 in Review

ALPS Advisors sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q4 2016, closing a stake of 962 shares — an estimated $70K sold.

ALPS Advisors first reported a position in SRRA in Q4 2015 and held it in 4 quarters. The position peaked at $596K in Q4 2015. 36 funds tracked by Wall St. Rank hold SRRA as of Q4 2016.

  • ALPS Advisors reported no remaining Sierra Oncology, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
  • ALPS Advisors sold 962 Sierra Oncology, Inc. Common Stock shares in Q4 2016, an estimated $70K.
  • ALPS Advisors first reported a position in Sierra Oncology, Inc. Common Stock in Q4 2015 and held it in 4 quarters.
  • ALPS Advisors's Sierra Oncology, Inc. Common Stock position peaked at $596K in Q4 2015.
  • 36 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q4 2016.

Based on ALPS Advisors's 13F filing for Q4 2016, filed 24 Jan 2017.